Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Biosimulation Market, by Product
1.4.2 North America Biosimulation Market, by Pricing Model
1.4.3 North America Biosimulation Market, by End Use
1.4.4 North America Biosimulation Market, by Application
1.4.5 North America Biosimulation Market, by Deployment Model
1.4.6 North America Biosimulation Market, by Therapeutic Area
1.4.7 North America Biosimulation Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis – Global
4.1 Market Share Analysis, 2023
4.2 Strategies Deployed in Biosimulation Market
4.3 Porter Five Forces Analysis
Chapter 5. North America Biosimulation Market by Product
5.1 North America Software Market by Region
5.2 North America Biosimulation Market by Software Type
5.2.1 North America Molecular Modeling & Simulation Software Market by Country
5.2.2 North America Clinical Trial Design Software Market by Country
5.2.3 North America PK/PD Modeling and Simulation Software Market by Country
5.2.4 North America Pbpk Modeling and Simulation Software Market by Country
5.2.5 North America Toxicity Prediction Software Market by Country
5.2.6 North America Other Software Type Market by Country
5.3 North America Services Market by Region
5.4 North America Biosimulation Market by Services Type
5.4.1 North America Contract Services Market by Country
5.4.2 North America Consulting Market by Country
5.4.3 North America Other Services Type Market by Country
Chapter 6. North America Biosimulation Market by Pricing Model
6.1 North America License-based Model Market by Country
6.2 North America Subscription-based Model Market by Country
6.3 North America Service-based Model Market by Country
6.4 North America Pay Per Use Model Market by Country
Chapter 7. North America Biosimulation Market by End Use
7.1 North America Life Sciences Companies Market by Country
7.2 North America Academic Research Institutions Market by Country
7.3 North America Other End Use Market by Country
Chapter 8. North America Biosimulation Market by Application
8.1 North America Drug Discovery & Development Market by Country
8.2 North America Disease Modeling Market by Country
8.3 North America Other Application Market by Country
Chapter 9. North America Biosimulation Market by Deployment Model
9.1 North America Cloud-based Market by Country
9.2 North America On-premises Market by Country
9.3 North America Hybrid Model Market by Country
Chapter 10. North America Biosimulation Market by Therapeutic Area
10.1 North America Oncology Market by Country
10.2 North America Cardiovascular Disease Market by Country
10.3 North America Infectious Disease Market by Country
10.4 North America Neurological Disorders Market by Country
10.5 North America Other Therapeutic Area Market by Country
Chapter 11. North America Biosimulation Market by Country
11.1 US Biosimulation Market
11.1.1 US Biosimulation Market by Product
11.1.1.1 US Biosimulation Market by Software Type
11.1.1.2 US Biosimulation Market by Services Type
11.1.2 US Biosimulation Market by Pricing Model
11.1.3 US Biosimulation Market by End Use
11.1.4 US Biosimulation Market by Application
11.1.5 US Biosimulation Market by Deployment Model
11.1.6 US Biosimulation Market by Therapeutic Area
11.2 Canada Biosimulation Market
11.2.1 Canada Biosimulation Market by Product
11.2.1.1 Canada Biosimulation Market by Software Type
11.2.1.2 Canada Biosimulation Market by Services Type
11.2.2 Canada Biosimulation Market by Pricing Model
11.2.3 Canada Biosimulation Market by End Use
11.2.4 Canada Biosimulation Market by Application
11.2.5 Canada Biosimulation Market by Deployment Model
11.2.6 Canada Biosimulation Market by Therapeutic Area
11.3 Mexico Biosimulation Market
11.3.1 Mexico Biosimulation Market by Product
11.3.1.1 Mexico Biosimulation Market by Software Type
11.3.1.2 Mexico Biosimulation Market by Services Type
11.3.2 Mexico Biosimulation Market by Pricing Model
11.3.3 Mexico Biosimulation Market by End Use
11.3.4 Mexico Biosimulation Market by Application
11.3.5 Mexico Biosimulation Market by Deployment Model
11.3.6 Mexico Biosimulation Market by Therapeutic Area
11.4 Rest of North America Biosimulation Market
11.4.1 Rest of North America Biosimulation Market by Product
11.4.1.1 Rest of North America Biosimulation Market by Software Type
11.4.1.2 Rest of North America Biosimulation Market by Services Type
11.4.2 Rest of North America Biosimulation Market by Pricing Model
11.4.3 Rest of North America Biosimulation Market by End Use
11.4.4 Rest of North America Biosimulation Market by Application
11.4.5 Rest of North America Biosimulation Market by Deployment Model
11.4.6 Rest of North America Biosimulation Market by Therapeutic Area
Chapter 12. Company Profiles
12.1 Certara, Inc.
12.1.1 Company Overview
12.1.2 Financial Analysis
12.1.3 Regional Analysis
12.1.4 Research & Development Expenses
12.1.5 Recent strategies and developments:
12.1.5.1 Product Launches and Product Expansions:
12.1.5.2 Acquisition and Mergers:
12.1.6 SWOT Analysis
12.2 Dassault Systemes SE
12.2.1 Company Overview
12.2.2 Financial Analysis
12.2.3 Regional Analysis
12.2.4 Research & Development Expense
12.2.5 SWOT Analysis
12.3 Advanced Chemistry Development, Inc.
12.3.1 Company Overview
12.4 Genedata AG (Danaher Corporation)
12.4.1 Company Overview
12.4.2 Financial Analysis
12.4.3 Segmental and Regional Analysis
12.4.4 Research & Development Expense
12.4.5 Recent strategies and developments:
12.4.5.1 Partnerships, Collaborations, and Agreements:
12.5 Instem Group of Companies
12.5.1 Company Overview
12.6 Chemical Computing Group ULC
12.6.1 Company Overview
12.7 Simulations Plus, Inc.
12.7.1 Company Overview
12.7.2 Financial Analysis
12.7.3 Segmental and Regional Analysis
12.7.4 Research & Development Expenses
12.7.5 Recent strategies and developments:
12.7.5.1 Partnerships, Collaborations, and Agreements:
12.7.5.2 Product Launches and Product Expansions:
12.7.5.3 Acquisition and Mergers:
12.7.6 SWOT Analysis
12.8 Schrodinger, Inc.
12.8.1 Company Overview
12.8.2 Financial Analysis
12.8.3 Segmental and Regional Analysis
12.8.4 Research & Development Expenses
12.9 PPD, Inc. (Thermo Fisher Scientific, Inc.)
12.9.1 Company Overview
12.9.2 Financial Analysis
12.9.3 Segmental and Regional Analysis
12.9.4 Research & Development Expenses
12.10. Physiomics Plc
12.10.1 Company Overview
12.10.2 Financial Analysis
Unique Offerings 